Previous studies have demonstrated that IL20RB was associated with the prognosis of various cancers, such as lung adenocarcinoma [28], pancreatic ductal adenocarcinoma [29], and pancreatic cancer [30]. Here, IL20RB is linked to pancreatic ductal adenocarcinoma.